Episodios

  • The Potential Role for GLP-1 Agonists in Asthma Treatment
    Mar 3 2026


    GLP-1 agonists have been blockbuster medications in diabetes and obesity but they may also have a surprising role in the treatment of asthma. Join the conversation as Katherine Cahill, MD, FAAAAI, discusses how GLP-1 agonists may improve asthma control and reduce airway inflammation.

    Find out more about asthma.

    Más Menos
    42 m
  • Boosting our Vaccine Knowledge: Updates, Allergy and Special Populations
    Feb 17 2026

    AVaccines are a cornerstone of public health, training the immune system to prevent infectious diseases, especially in our most vulnerable patients. In this episode, John Kelso, MD, FAAAAI, reviews recent vaccine developments, including the importance of measles vaccination amid ongoing outbreaks, updates to vaccination schedules, considerations when using vaccines with biologics and evaluation of vaccine allergy. Join us for a practical review of key vaccine updates to help you protect your patients.

    Find out more about the importance of vaccinations across age groups.

    Más Menos
    52 m
  • Penicillin Allergy Evaluation and Advocacy: How policy can make a difference for our patients
    Feb 3 2026

    Improving access to penicillin allergy evaluation for millions of older patients would lead to better antibiotic treatment, decreased surgical site infections and fewer cases of C. diff. The Penicillin Allergy Verification and Evaluation Act has the potential to do just this. Priya Bansal, MD, FAAAAI, and Allison Ramsey, MD, FAAAAI, share their valuable insight into the Act and how we can make advocacy a part of our practice.

    Find out more about the Penicillin Allergy Verification and Evaluation Act

    Más Menos
    35 m
  • Making the Most of the 2026 AAAAI Annual Meeting
    Jan 20 2026

    Julie Wang, MD, FAAAAI, shares highlights of the upcoming AAAAI Annual Meeting taking place in Philadelphia, Pennsylvania from February 27 to March 2. Listen in to hear what is in store this year as well as highlights such as the symposium on Philadelphia’s vaccine legacy as well as use of Artificial Intelligence and the new Practice Management Course.

    Visit the AAAAI Annual Meeting website.

    Más Menos
    22 m
  • Identifying and Managing Secondary Immune Deficiency
    Jan 6 2026

    As immunosuppressive therapies for cancer and autoimmune disease become more common, secondary immune deficiency is increasingly encountered in clinical practice. In this episode, Sara Barmettler, MD, FAAAAI, discusses the causes, diagnosis and management of secondary immune deficiency to help allergy and immunology physicians care for these patients effectively.

    Más Menos
    33 m
  • Advances in Treatment of Hereditary Angioedema
    Dec 16 2025

    Join hereditary angioedema expert Aleena Banerji, MD, FAAAAI, for a discussion about the diagnosis and management of hereditary angioedema, focusing on treatment developments that have dramatically improved the care of patients with HAE.

    Continuing Medical Education credit is available with this episode. Visit here to complete the assessment and claim credit. .75 AMA PRA Category 1 Credit(s)™

    Find out more about hereditary angioedema.

    US Hereditary Angioedema Association

    Más Menos
    35 m
  • The Diagnostic Dilemma of FPIES
    Dec 2 2025

    Diagnosing Food Protein Induced Enterocolitis Syndrome (FPIES) can be challenging and once diagnosed, there are few options for treatment other than strict avoidance and waiting for resolution. Sara Anvari, MD, MSc, FAAAAI, discusses the presentation and pathophysiology of FPIES and how treatment options beyond avoidance are evolving.

    Continuing Medical Education credit is available with this episode. Visit here to complete the assessment and claim credit. .75 AMA PRA Category 1 Credit(s)

    FPIES (Food Protein-Induced Enterocolitis Syndrome) Action Plan

    Más Menos
    44 m
  • Understanding Anaphylaxis
    Nov 18 2025

    How do families know when to give epinephrine and when to go to the ER? How long do we need to observe after an episode of anaphylaxis and who is at risk for recurrent symptoms? We discuss these important questions and more with Tim Dribin, MD, a pediatric emergency medicine physician, who is working to optimize emergency department care for patients with anaphylaxis.

    Learn more about anaphylaxis.

    Más Menos
    50 m